Get the Stockscreener App
2.98
4.49%
-0.14
After Hours:
3.13
0.15
+5.03%
Protagenic Therapeutics Inc stock is traded at $2.98, with a volume of 62,652.
It is down -4.49% in the last 24 hours and down -31.81% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$3.12
Open:
$3.09
24h Volume:
62,652
Relative Volume:
0.02
Market Cap:
$5.71M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-2.5913
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
-6.88%
1M Performance:
-31.81%
6M Performance:
-5.61%
1Y Performance:
-66.80%
1-Day Range:
$2.91
$3.11
1-Week Range:
$2.91
$3.32
52-Week Range:
$2.25
$15.26
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.98 | 5.97M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
Sentiment analysis tools applied to Protagenic Therapeutics Inc.2025 Technical Patterns & Consistent Income Trade Recommendations - newser.com
How to monitor Protagenic Therapeutics Inc. with trend dashboards2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com
Protagenic Therapeutics Inc. stock prediction for this weekJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock could be top winnerShare Buyback & Real-Time Volume Spike Alerts - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant rebound enough to break evenMarket Growth Review & Pattern Based Trade Signal System - newser.com
Why Protagenic Therapeutics Inc. stock could see breakout soonEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
Why retail traders accumulate Protagenic Therapeutics Inc. (MBP0) stockQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant reversing from oversold territoryEarnings Risk Summary & Expert Curated Trade Ideas - newser.com
Protagenic Therapeutics Inc. Equity Warrant stock chart pattern explained2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Measuring Protagenic Therapeutics Inc.’s beta against major indices2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
How Protagenic Therapeutics Inc. (MBP0) stock performs in easing cyclesJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock is favored by hedge fundsWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Does Protagenic Therapeutics Inc. Equity Warrant qualify in momentum factor screeningPortfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
What MACD signals say about Protagenic Therapeutics Inc.Portfolio Return Report & Precise Trade Entry Recommendations - newser.com
What Wall Street predicts for Protagenic Therapeutics Inc. Equity Warrant stock priceIndex Update & Long-Term Growth Plans - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock reach all time highs in 2025July 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
Heatmap analysis for Protagenic Therapeutics Inc. and competitors2025 Dividend Review & Reliable Breakout Stock Forecasts - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock outperform tech sector in 2025Trade Entry Report & Weekly Stock Breakout Alerts - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for hedge fundsMarket Trend Report & Reliable Price Breakout Alerts - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock outperform energy sector in 20252025 Biggest Moves & Weekly Momentum Stock Picks - newser.com
Using Bollinger Bands to evaluate Protagenic Therapeutics Inc.July 2025 Volume & Community Verified Trade Signals - newser.com
Why institutional investors increase stakes in Protagenic Therapeutics Inc. (MBP0) stockWatch List & Safe Capital Investment Plans - newser.com
Has Protagenic Therapeutics Inc. Equity Warrant formed a bullish divergence2025 Short Interest & Growth Focused Entry Point Reports - newser.com
Will Protagenic Therapeutics Inc. rebound enough to break evenEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Can Protagenic Therapeutics Inc. stock maintain operating marginsTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock trading near support levelsWeekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
Why Protagenic Therapeutics Inc. is moving today2025 Trading Volume Trends & Fast Moving Trade Plans - newser.com
Aug Chart Watch: Why Protagenic Therapeutics Inc. (MBP0) stock could be top winnerQuarterly Trade Review & Target Return Focused Picks - nchmf.gov.vn
Real time pattern detection on Protagenic Therapeutics Inc. stockWall Street Watch & Long-Term Capital Growth Strategies - newser.com
Has Protagenic Therapeutics Inc. Equity Warrant found a price floorTrade Entry Report & Free Daily Entry Point Trade Alerts - newser.com
Real time social sentiment graph for Protagenic Therapeutics Inc.GDP Growth & Weekly High Conviction Trade Ideas - newser.com
What recovery options are there for Protagenic Therapeutics Inc.Market Risk Report & Low Risk High Win Rate Stock Picks - newser.com
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):